Abstract
Results from a Phase Ib Evaluation of Tazemetostat (EPZ-6438) in Combination with R-CHOP in Poor Prognosis Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL): a Lysa Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have